Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endothelial Facilitation in Alzheimer's Disease
NCT01439555Phase 2Completed
- Sponsor
- University of Massachusetts
- Start
- Nov 2011
- Primary completion
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes, Allosteric Modulators, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of simvastatin, arginine, sapropterin in Alzheimer's disease (AD), Mild Cognitive Impairment (MCI), sponsored by University of Massachusetts. Started Nov 2011; status: completed.
02
Drugs
simvastatinargininesapropterin
03
Conditions
Alzheimer's disease (AD)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT01439555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01439555.